327 results
SC TO-T
EX-99
BMY
Bristol-Myers Squibb Co.
29 May 08
Third party tender offer statement
12:00am
by Bristol-Myers Squibb today at 7:00 a.m. Pacific / 10:00 a.m. Eastern. To access the live call, please dial 800.591.6942 (U.S.) or 617.614.4909 … (International), access code 40535858. Interested parties may listen to the webcast live at http://www.kosan.com by clicking on the "Webcasts" tab under
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
26 Apr 23
Bristol Myers Squibb Announces Leadership Transition Plan
4:35pm
new medicines. He has helped build a deep bench of commercial talent as well as industry-leading market access capabilities. These efforts have been … vital to helping us ensure patient access to critical medicines. We are confident that Chris, working together with Adam in his new role as Chief
DEFA14A
BMY
Bristol-Myers Squibb Co.
24 Mar 08
Additional proxy soliciting materials
12:00am
to you on the Internet. We encourage you to access and review all of the important information contained in the proxy materials before voting … will need your 12 digit control number(s) located on the following page to access these materials.
If you want to receive a paper or e-mail copy
DEFA14A
BMY
Bristol-Myers Squibb Co.
20 Apr 22
Additional proxy soliciting materials
4:30pm
eligible unemployed patients in the U.S. Expanded access to free BMS medicines, including some of our most widely prescribed products & those prescribed … diversity, equity & inclusion Ensuring health equity, patient access & innovation Social 2021 ≥ 25% new clinical trial sites in diverse metro areas 2022
DEFA14A
toegwd
19 Apr 21
Additional proxy soliciting materials
7:41am
DEFA14A
todiyqg4548zonzk
21 Mar 11
Additional proxy soliciting materials
12:00am
DEFA14A
edmd3x2kghfk5f
20 Mar 12
Additional proxy soliciting materials
12:00am
DEFA14A
i25xf
19 Mar 14
Additional proxy soliciting materials
12:00am
DEFA14A
zlyaf
26 Apr 23
Additional proxy soliciting materials
4:38pm
DEFA14A
cpf4fp41qf
22 Mar 10
Additional proxy soliciting materials
12:00am
DEFA14A
ljnw1umnplmpnxn wd
23 Mar 09
Additional proxy soliciting materials
12:00am
8-K
EX-99.2
zdost3
27 Jul 23
Bristol Myers Squibb Reports Second Quarter Financial Results for 2023
7:50am
8-K
EX-99.1
xwciamoooa5e
25 Mar 20
Other Events
9:15am
DEFA14A
i1hig5xyv5zgppy
10 Apr 23
Additional proxy soliciting materials
5:12pm
8-K
EX-99.3
fvs1r30an 77b99gs
24 Jan 19
Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results
8:54am
DEFA14A
u952v4toai9vq1i3ws
23 Apr 20
Additional proxy soliciting materials
8:59am
DEFA14A
v2asrpoc
19 Mar 99
Additional proxy soliciting materials
12:00am
8-K
EX-99.3
t5w5w8ebkbdzq
4 Feb 22
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021
7:50am